Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Nutrition and Cancer|January 13, 2021
Sesamol Upregulates Death Receptors and Acts as a Chemosensitizer in Solid Ehrlich Carcinoma Model in MiceNesma A Abd Elrazik, Mohamed El-Mesery, Amro El-Karef, et al.
Biochemical and Biophysical Research Communications|November 23, 2024
Carbenoxolone upregulates TRAIL\TRAILR2 expression and enhances the anti-neoplastic effect of doxorubicin in experimentally induced hepatocellular carcinoma in ratsIman M El-Zehery, Mohamed El-Mesery, Mohamed El-Sherbiny, et al.
Cytokine|June 5, 2018
Clinical significance of the TNF-α receptors, TNFRSF2 and TNFRSF9, on cell migration molecules Fascin-1 and Versican in acute leukemiaNabila El Kramani, Nehal M Elsherbiny, Amal M El-Gayar, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 8, 2021
Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatmentSahar A Helmy, Saif El-Mofty, Amal M El Gayar, et al.
Nanomedicine (London, England)|June 22, 2017
Nanoformulated natural therapeutics for management of streptozotocin-induced diabetes: potential use of curcumin nanoformulationYousra M El-Far, Mahmoud M Zakaria, Mahmoud M Gabr, et al.
Nanomedicine (London, England)|September 14, 2016
A newly developed silymarin nanoformulation as a potential antidiabetic agent in experimental diabetesYousra M El-Far, Mahmoud M Zakaria, Mahmoud M Gabr, et al.
The FEBS Journal|June 6, 2021
Resurrection and characterization of ancestral CYP11A1 enzymesPhilip Hartz, Silja J Strohmaier, Basma M El-Gayar, et al.
European Journal of Pharmacology|February 18, 2014
Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzymeAhmed Tayel, Khaled H Abd El Galil, Mohamed A Ebrahim, et al.
Pageof 5